The FluMist vaccine, manufactured by AstraZeneca, was approved in 2003 for health care providers to give patients, but the method has gotten renewed attention due to a new, broader approval. On Friday ...
AstraZeneca has a new at-home flu vaccine coming out. When will it arrive and how will it be administered? Here's what to ...
I love being able to go to the pharmacy for my own (or my kids’) flu shots. Pop in, get the shot, then go about my day. That ...
The FDA approved FluMist, a nasal spray flu vaccine for self-administration, making it the first flu vaccine of its kind available for at home use.
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...
AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...
Since its initial US approval in 2003, 200 million doses of FluMist have been distributed globally. The new ...
The U.S. Food and Drug Administration (FDA) has approved FluMist for self-administration. On Friday, the FDA announced that ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
Recent health developments include the EU backing Novo Nordisk's Wegovy for obesity-related heart conditions, FDA approvals ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first “self-administered” influenza vaccine — though a delay in the change ...
The AstraZeneca vaccine FluMist, which is administered in nasal spray form, was first approved by the FDA in 2003 for people ...